Janeta Popovici-Müller

4.2k total citations
20 papers, 578 citations indexed

About

Janeta Popovici-Müller is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Janeta Popovici-Müller has authored 20 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Hematology. Recurrent topics in Janeta Popovici-Müller's work include Acute Myeloid Leukemia Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Glioma Diagnosis and Treatment (4 papers). Janeta Popovici-Müller is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Glioma Diagnosis and Treatment (4 papers). Janeta Popovici-Müller collaborates with scholars based in United States, China and India. Janeta Popovici-Müller's co-authors include Stefan Größ, Lenny Dang, Scott A. Biller, Kimberly Straley, Katharine Yen, Gerald W. Shipps, Valeria R. Fantin, Shinsan M. Su, Yongqi Deng and Hua Yang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Janeta Popovici-Müller

20 papers receiving 567 citations

Peers

Janeta Popovici-Müller

GENET

HEMAT

Anna Frenzel Sweden

Naoki Teno Japan

Alan G. Olivero United States

Xavier Billot Canada

Elin Lindhagen Sweden

Christopher Straub United States

Ayşe Latif United Kingdom

Ji Ma China

Mun Chiang Chan United Kingdom

Eloisi Caldas-Lopes United States

Anna Frenzel Sweden

Janeta Popovici-Müller

678 ×2.1

264 ×1.3

53 ×0.4

GENET

33 ×0.5

HEMAT

36 ×0.5

Citations per year, relative to Janeta Popovici-Müller Janeta Popovici-Müller (= 1×) peers Anna Frenzel

Countries citing papers authored by Janeta Popovici-Müller

Since Specialization

Citations

This map shows the geographic impact of Janeta Popovici-Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janeta Popovici-Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janeta Popovici-Müller more than expected).

Fields of papers citing papers by Janeta Popovici-Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janeta Popovici-Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janeta Popovici-Müller. The network helps show where Janeta Popovici-Müller may publish in the future.

Co-authorship network of co-authors of Janeta Popovici-Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Janeta Popovici-Müller. A scholar is included among the top collaborators of Janeta Popovici-Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janeta Popovici-Müller. Janeta Popovici-Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yue, N. Nagaraja, Bin Fan, et al.. (2021). Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant Malignancies. Drug Metabolism and Disposition. 49(10). 870–881. 7 indexed citations

Nagaraja, Raj, Andrew Olaharski, Rohini Narayanaswamy, et al.. (2020). Preclinical toxicology profile of squalene epoxidase inhibitors. Toxicology and Applied Pharmacology. 401. 115103–115103. 17 indexed citations

Padyana, Anil K., Stefan Größ, Lei Jin, et al.. (2019). Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase. Nature Communications. 10(1). 99 indexed citations

Yen, Katharine, Zenon Konteatis, Zhihua Sui, et al.. (2018). Abstract B126: AG-881, a brain penetrant, potent, pan-mutant IDH (mIDH) inhibitor for use in mIDH solid and hematologic malignancies. Molecular Cancer Therapeutics. 17(1_Supplement). B126–B126. 16 indexed citations

Davis, Mindy I., Stefan Größ, Min Shen, et al.. (2014). Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1. Journal of Biological Chemistry. 289(20). 13717–13725. 72 indexed citations

Hansen, Erica, Cyril Quivoron, René M. Lemieux, et al.. (2014). AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex Vivo. Blood. 124(21). 3734–3734. 40 indexed citations

Labroli, Marc, Michael P. Dwyer, Ruichao Shen, et al.. (2014). The identification of novel 5′-amino gemcitabine analogs as potent RRM1 inhibitors. Bioorganic & Medicinal Chemistry. 22(7). 2303–2310. 10 indexed citations

Chen, Yue, Fang Wang, René M. Lemieux, et al.. (2014). Abstract 1194: IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human Idh1 mutant AML xenograft model. Cancer Research. 74(19_Supplement). 1194–1194. 3 indexed citations

Deng, Yongqi, Gerald W. Shipps, Lianyun Zhao, et al.. (2013). Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor. Bioorganic & Medicinal Chemistry Letters. 24(1). 199–203. 17 indexed citations

10.

Yen, Katharine, René M. Lemieux, Janeta Popovici-Müller, et al.. (2013). IDH1 Mutant Inhibitor Induces Cellular Differentiation and Offers a Combination Benefit With Ara-C In a Primary Human Idh1 Mutant AML Xenograft Model. Blood. 122(21). 3946–3946. 13 indexed citations

11.

Davis, Mindy I., Rajan Pragani, Janeta Popovici-Müller, et al.. (2013). ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells. Europe PMC (PubMed Central). 16 indexed citations

12.

Labroli, Marc, Michael P. Dwyer, Ruichao Shen, et al.. (2013). Syntheses of 5′-amino-2′,5′-dideoxy-2′,2′-difluorocytidine derivatives as novel anticancer nucleoside analogs. Tetrahedron Letters. 55(3). 598–602. 5 indexed citations

13.

Popovici-Müller, Janeta, Jeffrey O. Saunders, Francesco G. Salituro, et al.. (2012). Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo. ACS Medicinal Chemistry Letters. 3(10). 850–855. 160 indexed citations

14.

Spencer, Thomas A., et al.. (2010). Bridged aromatic alkenes for the study of carbocation–π interaction. Tetrahedron. 66(25). 4441–4451. 9 indexed citations

15.

Deng, Yongqi, Gerald W. Shipps, Tong Wang, et al.. (2009). Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 19(18). 5363–5367. 12 indexed citations

16.

Popovici-Müller, Janeta, Gerald W. Shipps, K Rösner, et al.. (2009). Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase. Bioorganic & Medicinal Chemistry Letters. 19(22). 6331–6336. 22 indexed citations

17.

Annis, D. Allen, Gerald W. Shipps, Yongqi Deng, et al.. (2007). Method for Quantitative Protein−Ligand Affinity Measurements in Compound Mixtures. Analytical Chemistry. 79(12). 4538–4542. 37 indexed citations

18.

Spencer, Thomas A., et al.. (2006). Preparation and biochemical evaluation of fluorenone-containing lipid analogs. Bioorganic & Medicinal Chemistry Letters. 16(11). 3000–3004. 6 indexed citations

19.

Shipps, Gerald W., Yongqi Deng, Tong Wang, et al.. (2004). Aminothiazole inhibitors of HCV RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 15(1). 115–119. 12 indexed citations

20.

Popovici-Müller, Janeta & Thomas A. Spencer. (1997). The singular reduction of 1,8-bis-hydroxymethylnaphthalene to a benzonorcaradiene by LiAlH4. Tetrahedron Letters. 38(47). 8161–8164. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact